Courtney T. Van Geelen
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Germline BRCA1 pathogenic variants and T cell dysfunction.
Journal: Immuno-oncology technology
Published: August 14, 2026
Baseline tumour burden and prognosis in breast cancer treated with immune checkpoint inhibitors.
Journal: Breast (Edinburgh, Scotland)
Published: March 19, 2025
Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2-Low, Hormone Receptor-Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical Trials.
Journal: JCO precision oncology
Published: January 24, 2025
Parity and lactation induce T-cell-mediated breast cancer protection.
Journal: Nature
Published: August 02, 2024
Sustained lymphocyte decreases after treatment for early breast cancer.
Journal: NPJ breast cancer
Published: March 26, 2024
BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programme.
Journal: Histopathology
Published: November 24, 2022
Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients.
Journal: Breast cancer research : BCR
Published: July 15, 2022
Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II Study.
Journal: Cancer discovery
Published: December 30, 2021
Clinical implications of prospective genomic profiling of metastatic breast cancer patients.
Journal: Breast cancer research : BCR
Published: May 11, 2020
FGFR2 amplification in metastatic hormone-positive breast cancer and response to an mTOR inhibitor.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 22, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026